Effectiveness and prognostic factors of Cetuximab plus chemotherapy for recurrent or metastatic head and neck cancer
Author:
Affiliation:
1. Department of Otolaryngology and Head and Neck Surgery, Kansai Medical University Hospital
2. Department of Radiation Oncology, Kansai Medical University Hospital
3. Department of Dentistry and Oral Surgery, Kansai Medical University Hospital
Publisher
Japan Society for Head and Neck Cancer
Subject
Oncology,Otorhinolaryngology
Link
https://www.jstage.jst.go.jp/article/jjhnc/43/4/43_493/_pdf
Reference20 articles.
1. 1) Christensen M.E., Therkildsen M.H., Hansen B.L., et al: Epidermal growth factor receptor expression on oral mucosa dysplastic epithelia and squamous cell carcinomas. European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies 249:243-247, 1992
2. 2) Fujii S., Uryu H., Akashi K., et al: Clinical significance of KRAS gene mutation and epidermal growth factor receptor expression in Japanese patients with squamous cell carcinoma of the larynx, oropharynx and hypopharynx. International Journal of Clinical Oncology 18:454-463, 2013
3. 3) Rubin Grandis J., Melhem M.F., Barnes E.L., et al: Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer 78:1284-1292, 1996
4. 4) Vermorken J.B., Mesia R., Rivera F., et al: Platinum-based chemotherapy plus cetuximab in head and neck cancer. The New England Journal of Medicine 359:1116-1127, 2008
5. 5) Vermorken J.B., Herbst R.S., Leon X., et al: Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies. Cancer 112:2710-2719, 2008
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Total accumulated dose of cisplatin and EXTREME regimen for recurrent and metastatic head and neck carcinoma;JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3